Previous 10 | Next 10 |
2024-05-14 20:48:10 ET TRACON Pharmaceuticals, Inc. (TCON) Q1 2024 Earnings Conference Call May 14, 2024 04:30 PM ET Company Participants Charles Theuer - President & CEO Scott Brown - CFO Conference Call Participants Matthew Venezia - Alliance Global...
2024-05-14 16:03:45 ET More on Tracon TRACON Pharmaceuticals, Inc. (TCON) Q4 2023 Earnings Call Transcript Tracon Pharma drops after pivotal data for cancer drug Seeking Alpha’s Quant Rating on Tracon Historical earnings data for Tracon Financi...
SAN DIEGO, May 14, 2024 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development platform to advance its pipeline of novel targeted cancer therapeutics and to partner with other life...
SAN DIEGO, May 07, 2024 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development platform to advance its pipeline of novel targeted cancer therapeutics and to partner with other life...
2024-04-18 08:15:07 ET Losers: Lithium Americas Corp LAC -24% on plans for 55M-share offering . NRX Pharmaceuticals NRXP -22% announces proposed underwritten public offering of common stock . Canaan CAN -22% files for $300M mixed shelf offering . Ic...
A look at the top 10 most actives in the United States SiNtx Technologies Inc. (SINT) rose 62.9% to $0.0373 on volume of 466,310,671 shares INVO BioScience Inc. (INVO) rose 139.5% to $1.82 on volume of 225,666,770 shares PROSHARES TRUST (SQQQ) rose 3.7% to $11.86 on volume of 167,545,988 ...
2024-04-12 17:00:00 ET More on Tracon Tracon Pharma drops after pivotal data for cancer drug Seeking Alpha’s Quant Rating on Tracon Historical earnings data for Tracon Financial information for Tracon Read the full article on Seeking Alpha ...
2024-04-10 10:02:03 ET More on Health Care Select Sector SPDR XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run Well...
A look at the top 10 most actives in the United States Auddia Inc. (AUUD) rose 147.6% to $3.54 on volume of 159,627,983 shares Beneficient (BENF) rose 61.2% to $0.083 on volume of 129,486,507 shares Tesla Inc. (TSLA) rose 4.9% to $172.98 on volume of 103,974,146 shares Selina Hospitalit...
A look at the top 10 most actives in the United States Kintara Therapeutics Inc. (KTRA) rose 63.3% to $0.164 on volume of 223,092,889 shares C3is Inc. (CISS) rose 24.2% to $0.0508 on volume of 148,576,579 shares Nikola Corporation (NKLA) fell 8.4% to $0.8918 on volume of 128,870,418 share...
News, Short Squeeze, Breakout and More Instantly...
TRACON Pharmaceuticals Inc. Company Name:
TCON Stock Symbol:
NASDAQ Market:
TRACON Pharmaceuticals Inc. Website:
A look at the top 10 most actives in the United States Zoomcar Holdings Inc. (ZCAR) rose 58.3% to $0.2162 on volume of 130,087,791 shares Maxeon Solar Technologies Ltd. (MAXN) rose 3.6% to $0.1863 on volume of 71,767,970 shares SMX (Security Matters) Public Limited Company (SMX) rose 17.1...
A look at the top 10 most actives in the United States Senti Biosciences Inc. (SNTI) rose 51.3% to $0.4175 on volume of 386,768,896 shares NVIDIA Corporation (NVDA) rose 0.6% to $124.3 on volume of 277,459,318 shares PROSHARES TRUST (SQQQ) fell 1.9% to $8.12 on volume of 139,088,335 share...
2024-07-01 12:15:02 ET H.C. Wainwright analyst issues NEUTRAL recommendation for TCON on July 1, 2024 11:46AM ET. The previous analyst recommendation was Buy. TCON was trading at $1.44 at issue of the analyst recommendation. The overall analyst consensus : BUY. Curre...